Argenica Therapeutics Ltd (AU:AGN) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Argenica Therapeutics Limited announced the cessation of 600,000 options due to their expiry on June 10, 2024, without being exercised or converted. This financial update is relevant for investors tracking changes in the company’s issued capital.
For further insights into AU:AGN stock, check out TipRanks’ Stock Analysis page.